#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinoblastoma Cardiac amyloidosis Piriformis syndrome Encephalopathy neonatal Frontotemporal dementia Squamous cell carcinoma of the hypopharynx Transitional cell carcinoma Postprandial hypoglycaemia Hereditary angioedema Rheumatoid arthritis Deafness Acute graft versus host disease in intestine Prostate cancer Systemic sclerosis pulmonary Cutaneous lupus erythematosus More trials…

    Learn about Rare Diseases

    Sjogren’s syndrome – Diagnostics Hairy cell leukaemia recurrent – Basic Information Prolymphocytic leukaemia – Basic Information Wolfram syndrome – Life with Disease Wiskott-Aldrich syndrome – Life with Disease Familial haemophagocytic lymphohistiocytosis – Treatment Retinoblastoma – Treatment Advanced systemic mastocytosis – Treatment Anaplastic thyroid cancer – Treatment Cerebral arteriovenous malformation haemorrhagic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TUVATEXIB GSK4524101A Gsk3739937 Camlipixant Tazobactam Tovinontrine RO7288817 Munc-Cd34 Rocatinlimab Psma-11 Doconexent Molgramostim Ibuprofen Sodium Dihydrate Vixarelimab Fremanezumab Aceclofenac Acasunlimab Dermatophagoides Farinae Eletriptan Utreloxastat More therapies…

    Learn about Your Condition

    Cachexia Alcoholism Bladder cancer Metastases to lymph nodes Colon cancer stage III Staphylococcal infection Ankylosing spondylitis Mitral valve incompetence Pulmonary hypertension Arteriospasm coronary Vulval cancer recurrent Sinusitis bacterial Colon cancer stage II Blood iron increased Skin ulcer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • A study testing how well patiromer lowers high potassium levels in the blood in children under 12 years of age with hyperkalemia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hyperkalaemia
    Investigated Drugs:
    • Patiromer
    Belgium Finland France Greece Hungary Italy +5

  • Sodium-glucose cotransporter-2 inhibitor drug combination for patients with diabetes and heart attack to slow coronary artery disease progression

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetes mellitus
    • Acute myocardial infarction
    Investigated Drugs:
    • Canagliflozin
    • Empagliflozin
    • Dapagliflozin
    Italy

  • A Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is

    Recruiting

    4 1
    Investigated Diseases:
    • Cachexia
    Investigated Drugs:
    • VISUGROMAB
    Bulgaria Czechia France Germany Ireland Italy +5

  • Long-term study of bitopertin safety and effectiveness in patients with erythropoietic protoporphyria or X-linked protoporphyria

    Recruiting

    3 1 1
    Belgium France Germany Ireland Italy The Netherlands +3

  • A study testing finerenone compared to placebo in patients with chronic kidney disease who are not taking renin-angiotensin-system inhibitors

    Recruiting

    3 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Finerenone
    Spain

  • A Study of SAB-142 to Slow the Progression of Type 1 Diabetes in Adults and Children Recently Diagnosed with the Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    • HUMAN POLYCLONAL IMMUNOGLOBULIN G AGAINST THYMOCYTE
    • Sodium Chloride
    Austria Belgium Denmark Finland France Germany +5
Previous Page
1 … 4 5 6 7 8 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!